Sopharma

Sopharma’s 2022 net profit down by 15%

Leading pharmaceuticals manufacturer and distributor Sopharma posted a slowdown in terms of net profit, down by 15% YoY to BGN 77.9M. This is mainly due to acquisition of and exemption from subsidiaries in the amount of BGN 36.1 million, as well as the accrued 2022 impairments of non-current assets in the amount of BGN 20.8 million.

ELANA Trading has a 29 years of history on financial markets, offering a wide range of services and markets. ELANA Trading quality service has been recognized by 24 industry awards. The broker is part of the international brokers’ network of US Auerbach Grayson & Co. since 1998 and maintains long-term partnerships with a lot of international financial institutions.

ELANA Trading is part of ELANA group - one of the largest groups in the non-banking financial sector in Bulgaria.

Contacts

Dimitar Georgiev
Head of Trading
Phone: +359 (2) 81 000 25
Email: georgievd@elana.net

Tatyana Puncheva-Vasileva
Head of Research
Phone: +359 (2) 81 000 24
Email: vasileva@elana.net

Contacts

Sopharma Business Towers,
Tower B, Floors 12-13,
5, Lachezar Stanchev St,
1797 Sofia, Bulgaria

Phone: +359 (2) 81 000 25
Phone: +359 (2) 81 000 26
Email: bgtrader@elana.net
Disclaimer: This website represents ELANA Trading with the sole purpose to provide information. The data published on the website is not provided to be used as a background for specific investment decisions. No publication of ELANA Trading should be construed as an offer (or solicitation of an offer) to U.S. persons to buy or sell financial instruments or any financial product, make any investment or participate in any particular trading strategy (collectively “Offers”). No Publication of ELANA Trading should be construed as an Offer (or solicitation of an offer) in any jurisdiction in which such Offer would be illegal. Any such perceived Offer will not be honoured by ELANA Trading.

© 1991 - 2024 ELANA | ELANA Trading Privacy policy Manage cookie consent